YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Gilead reaches HIV drug deal with White House

Posted online

Pharmaceutical maker Gilead Sciences reached an agreement with the Trump administration.

Under the agreement, Gilead will donate drugs that reduce the risk of HIV transmission to up to 200,000 people annually.

The drugs usually sell for $1,600 to $2,000 a month.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Graduating to Work: MSU program connects employers with grad students for long-term assistantships

A Missouri State University program that brings together graduate students and local employers is growing after an extended pilot launch.

Most Read
Update cookies preferences